GlassScriptPhysician profile
Sandra Dee Richards
NPI 1497570337
$574.18
in general payments reported to CMS, 2019-2025
13 companies · $574 in 2025
The $574 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $79.45 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.75 | 2025 | |
| Merck Sharp & Dohme LLC | $66.42 | 2025 | Keytruda, Welireg, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $55.92 | 2025 | Lynparza, Enhertu |
| Genzyme Corporation | $52.87 | 2025 | |
| Puma Biotechnology, INC. | $49.79 | 2025 | |
| Geron Corporation | $47.23 | 2025 | Rytelo |
| Caris Mpi, INC. | $30.62 | 2025 | Mi Cancer Seek |
| Emd Serono, INC. | $28.81 | 2025 | |
| Csl Behring | $25.76 | 2025 | Hizentra |
| Exelixis INC. | $23.60 | 2025 | Cabometyx |
| Lilly USA, LLC | $21.58 | 2025 | Verzenio, Jaypirca |
| Sobi, INC | $18.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.